"Analysis of naïve Patients With Age-related Macular Degeneration of the Neovascular Type and Treated With Aflibercept (Eylea®) in Treat-and-extend at CHU Brugmann"

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

April 13, 2021

Primary Completion Date

September 22, 2021

Study Completion Date

September 22, 2021

Conditions

Age-related Macular Degeneration

Interventions

OTHER

Data extraction from medical files

Trial Locations (1)

CHU Brugmann, Brussels

All Listed Sponsors

lead

Laurence Postelmans

OTHER